GDC-0084 inhibits cutaneous squamous cell carcinoma cell growth
Journal Article
·
· Biochemical and Biophysical Research Communications
- Department of Plastic Surgery, The Second Affiliated Hospital of Soochow University, Suzhou (China)
- Department of Burns and Plastic Surgery, The Third Affiliated Hospital of Nantong University, Wuxi, Jiangsu (China)
Highlights: • GDC-0084 is a novel small-molecule PI3K/mTOR dual inhibitor. • GDC-0084 inhibits cutaneous squamous cell carcinoma (cSCC) cell survival/proliferation. • GDC-0084 induces apoptosis activation in cSCC cells. • GDC-0084 blocks PI3K-Akt-mTOR and DNA-PKcs signaling activation in cSCC cells. • Gastric gavage of GDC-0084 inhibits A431 xenograft tumor growth in SCID mice. GDC-0084 is a novel and potent small-molecule PI3K-mTOR dual inhibitor. The present study examined its potential activity in cutaneous squamous cell carcinoma (cSCC) cells. Our results show that GDC-0084 treatment at nanomole concentrations potently inhibited survival and proliferation of established (A431, SCC-13 and SCL-1 lines) and primary human cSCC cells. GDC-0084 induced apoptosis activation and cell cycle arrest in the cSCC cells. It was more efficient than other known PI3K-Akt-mTOR inhibitors in killing cSCC cells, but was non-cytotoxic to the normal human skin fibroblasts/keratinocytes. In A431 cells and primary cSCC cells, GDC-0084 blocked phosphorylation of key PI3K-Akt-mTOR components, including p85, Akt, S6K1 and S6. GDC-0084 also inhibited DNA-PKcs activation in cSCC cells. Significantly, restoring DNA-PKcs activation by a constitutively active-DNA-PKcs (S2056D) partially inhibited GDC-0084-induced cell death and apoptosis in A431 cells. In vivo, GDC-0084 daily gavage potently inhibited A431 xenograft tumor growth in mice. In GDC-0084-treated tumor tissues PI3K-Akt-mTOR and DNA-PKcs activation were significantly inhibited. In summary, GDC-0084 inhibits human cSCC cell growth in vitro and in vivo through blocking PI3K-Akt-mTOR and DNA-PKcs signalings.
- OSTI ID:
- 23105536
- Journal Information:
- Biochemical and Biophysical Research Communications, Journal Name: Biochemical and Biophysical Research Communications Journal Issue: 3 Vol. 503; ISSN 0006-291X; ISSN BBRCA9
- Country of Publication:
- United States
- Language:
- English
Similar Records
Vorinostat, an HDAC inhibitor attenuates epidermoid squamous cell carcinoma growth by dampening mTOR signaling pathway in a human xenograft murine model
Dual inhibition of BRD4 and PI3K by SF2523 suppresses human prostate cancer cell growth in vitro and in vivo
The anti-hepatocellular carcinoma cell activity by a novel mTOR kinase inhibitor CZ415
Journal Article
·
Mon Jan 14 23:00:00 EST 2013
· Toxicology and Applied Pharmacology
·
OSTI ID:22216036
Dual inhibition of BRD4 and PI3K by SF2523 suppresses human prostate cancer cell growth in vitro and in vivo
Journal Article
·
Sun Jan 14 23:00:00 EST 2018
· Biochemical and Biophysical Research Communications
·
OSTI ID:23134450
The anti-hepatocellular carcinoma cell activity by a novel mTOR kinase inhibitor CZ415
Journal Article
·
Sat Jun 03 00:00:00 EDT 2017
· Biochemical and Biophysical Research Communications
·
OSTI ID:22697040